A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...
1 Department of Veterinary Biomedical Sciences, Oregon State University, Corvallis, OR, United States 2 Department of Biology, Missouri State University, Springfield, MO, United States Respiratory ...
CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and ...
The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a potential ...
Wells Fargo has upgraded CareDx (NASDAQ:CDNA) to equal weight from underweight, citing valuation, but lowered its price target for the stock. The investment bank said that following a roughly 30% ...
CareDx CDNA shares rallied 6.1% in the last trading session to close at $25.07. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.
According to latest report, the global DNA and gene chip market size is calculated at USD 11.44 billion in 2024 and is projected to hit around USD 30.72 billion by 2033, expanding at a CAGR of 11.6% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback